Molecular Diagnostics Market Sales

Molecular Diagnostics Market to See 8.4% CAGR Growth to 2024: Growth Factor & Trends

Posted on Updated on

MarketStudyReport.com adds a new Molecular Diagnostics Market research report that provides a detailed market overview as well as industry analysis for / of companies, manufacturers and distributors covering data on gross margin, cost structure, consumption value, sale price and more.

Growing geriatric population base along with rising incidences of infectious diseases will act as high impact rendering factors for Molecular Diagnostics Market. Elderly people prone to suffer from several diseases require continuous monitoring as well as diagnostic tests for various diseases. Multifactorial benefits and applications of molecular diagnostics in therapeutic monitoring, detection of predisposition to disease, patient stratification, drug regimen selection and others will drive molecular diagnostics market growth.

Request a sample copy of Molecular Diagnostics Market Research Report @ https://www.marketstudyreport.com/request-a-sample/467710/?utm_source=WP-SK

Molecular Diagnostics Market is set to exceed USD 12.5 billion by 2024; according to a new research report.

Technological advancements including target specific PCR, high throughput capacity has escalated level of disease diagnosis in less time as compared to conventional method will favor molecular diagnostics market growth. Growing awareness about several diseases, diagnosis and prevention has stimulated demand for diagnostic tests.

Growing adoption of western culture, unhealthy dietary habits and physical inactivity has led to upsurge in several chronic disease incidences. Increasing prevalence of infectious diseases in developing countries such as India coupled with growing demand for point of care diagnostic technologies (POCT) will fuel business growth.

Growth of home healthcare sector coupled with technological advancements in handheld POCT devices will drive molecular diagnostics market growth. Rising demand for cost effective disease diagnostic tests has accelerated rise in R&D investment for development of molecular diagnostic platform. Significant role of molecular testing in diagnosis of cancer and sexually transmitted disease will positively impact industry growth.  However, complex nature of U.S. FDA approval for molecular diagnostic technology coupled with rising costs associated with molecular testing will hinder molecular diagnostics market growth over the forecast period.

Enquire about this report @ https://www.marketstudyreport.com/enquiry-before-buying/467710/?utm_source=wp-SK

Infectious disease segment held largest revenue share in 2016 and is expected to follow similar trend over the forecast timeframe due to increasing incidences of infectious diseases in developing countries of Asia Pacific and Latin America. Growing awareness about pre-disease diagnosis will fuel molecular diagnostics market growth.

Sequencing is poised to be fastest growing technological segment during the forecast timeframe owing to advancement in next-generation sequencing technology and its application in cancer diagnosis and characterization. High throughput capability along with rising automation in pre-sequencing protocols will drive molecular diagnostics market.

U.S. molecular diagnostics market held largest revenue share in 2016 due to growing geriatric population, highly susceptible to suffer from various illnesses along with high technological adoption rate of U.S. Increasing healthcare expenditure by government as well as individual will positively impact market growth.

China molecular diagnostics market should grow at significant rate due to growing demand for advanced treatment coupled with rising prevalence of infectious diseases such as hepatitis in the country. Increasing number of baby boomers will act as primary driver for industry growth. Increasing focus of industry players towards expanding country’s molecular diagnostics platform coupled with rising adoption of PCR and locally manufactured diagnostic kits in the country will favor Chine molecular diagnostics market growth.

Some of the key industry players operating in global molecular diagnostics market are Abbott, Alere, Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories, Danaher Corporation, GenMark Diagnostics, HTG Molecular Diagnostics, Johnson & Johnson, MDxHealth, Novartis (Grifols), Qiagen Gaithersburg, Siemens Healthcare and Roche. Industry players are focusing their efforts towards developing new cost-effective, highly accurate and easy operative molecular diagnostic products to satisfy increasing consumer demand along with consolidate its market position. Strategic partnership, alliances, mergers and acquisitions are major strategies followed by market players.

Related Reports: –

Global POC Molecular Diagnostics Market 2017-2021

About POC Molecular Diagnostics POC molecular diagnostics help in identification, treatment, and prevention of infectious diseases, oncology, hematology, and prenatal diseases. The demand for POC mol…

https://www.marketstudyreport.com/reports/global-poc-molecular-diagnostics-market-2017-2021/?utm_source=RR-SK

About Us:
Centralize market research purchases across your entire organization in one place. Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

The Green Suite #4594,

Dover, DE 19901

United States

Phone: 1-201-355-0868

US Toll Free: 1-866-764-2270

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

News: https://www.marketstudyreport.com/category/news-releases/

Connect with us: Google+ | LinkedIn | Twitter